“…A recurring issue in attempts to use oxytocin as a medicine is the need to understand its role in behavioral and physiologic adaptations and resilience in the face of stressors and trauma. Nervous system activity, neural connectivity, and responses to social stimuli have been related to peripheral peptide concentrations in both neurotypical individuals ( Lancaster et al, 2018a ) and those diagnosed with various mental illnesses, such as schizophrenia or bipolar disorder ( Rubin et al, 2018 ). Peripheral levels of oxytocin and vasopressin or variations in their receptors have been associated with function in Williams syndrome ( Dai et al, 2012 ), autism spectrum disorders ( Oztan et al, 2018b ), schizophrenia ( Rubin et al, 2014 , 2018 ), depression ( Cyranowski et al, 2008 ; Goekoop et al, 2011 ), postpartum depression ( Zelkowitz et al, 2014 ; Bell et al, 2015 ), borderline personality disorders ( Brune, 2016 ), eating disorders ( Aulinas et al, 2019 ), and substance abuse ( Buisman-Pijlman et al, 2014 ).…”